- Home
- AUTL vs ALTI Comparison
AUTL vs ALTI Comparison
Compare AUTL & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | ALTI |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United Kingdom | United States |
| Employees | N/A | 490 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 407.2M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AUTL | ALTI |
|---|---|---|
| Price | $1.59 | $3.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 116.8K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.11 |
| EPS | N/A | ★ N/A |
| Revenue | $10,120,000.00 | ★ $254,956,000.00 |
| Revenue This Year | $84.74 | $18.06 |
| Revenue Next Year | $65.76 | $10.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 496.00 | 23.21 |
| 52 Week Low | $1.15 | $2.96 |
| 52 Week High | $2.70 | $5.45 |
Technical Indicators
Market Signals| Indicator | AUTL | ALTI |
|---|---|---|
| Relative Strength Index (RSI) | 59.85 | 51.69 |
| Support Level | $1.22 | $3.73 |
| Resistance Level | $1.69 | $3.95 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 74.03 | 78.58 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About ALTI AlTi Global Inc.
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.